Hypertonic Saline Therapy in Ambulatory Heart Failure Unit.

PHASE3CompletedINTERVENTIONAL
Enrollment

167

Participants

Timeline

Start Date

January 1, 2021

Primary Completion Date

May 10, 2023

Study Completion Date

September 30, 2023

Conditions
Heart Failure
Interventions
DRUG

Hypertonic saline solution plus intravenous furosemide

"Intravenous 60-minutes of hypertonic saline therapy plus furosemide:~Furosemide:~125 mg if home oral furosemide ≤160 mg, 250 mg if home oral furosemide \> 160 mg~Hypertonic saline solution:~Na+ 125-134: 3.4%, Na+ 135-145: 2.6%"

DRUG

Intravenous furosemide

"Intravenous 60-minutes infusion of furosemide:~125 mg if home oral furosemide ≤ 160 mg, 250 mg if home oral furosemide \> 160 mg"

Trial Locations (14)

10003

Hospital San Pedro de Alcántara, Cáceres

25198

Hospital Universitario Arnau de Vilanova, Lleida

28006

Hospital Universitario La Princesa, Madrid

28034

Hospital Universitario Ramón y Cajal, Madrid

28040

Hospital Clinico Universitario San Carlos, Madrid

28041

Hospital Universitario Doce de Octubre, Madrid

28222

Hospital Universitario Puerta de Hierro, Majadahonda

28933

Hospital Universitario Rey Juan Carlos, Móstoles

29010

Hospital Universitario Virgen de la Victoria, Málaga

46010

Hospital Clinico Universitario de Valencia, Valencia

46014

Hospital General Universitario de Valencia, Valencia

50009

Hospital Clínico Universitario Lozano de Blesa, Zaragoza

08041

Hospital de la Santa Creu i Santa Pau (Fundación Privada Hospital de la Santa Creu i Sant Pau, Barcelona

08907

Hospital Universitari de Bellvitge, Barcelona

All Listed Sponsors
collaborator

Instituto de Salud Carlos III

OTHER_GOV

collaborator

Spanish Society of Cardiology

OTHER

lead

Puerta de Hierro University Hospital

OTHER

NCT04533997 - Hypertonic Saline Therapy in Ambulatory Heart Failure Unit. | Biotech Hunter | Biotech Hunter